Juan Lei
Overview
Explore the profile of Juan Lei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
763
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheng K, Chen J, Xu R, Sun H, Liu R, Wang Y, et al.
J Transl Med
. 2025 Mar;
23(1):334.
PMID: 40087752
No abstract available.
2.
Sheng K, Chen J, Xu R, Sun H, Liu R, Wang Y, et al.
J Transl Med
. 2025 Feb;
23(1):148.
PMID: 39905485
Background: Chromatin accessibility plays a crucial role in mediating transcriptional dysregulation and heterogeneity in Esophageal Squamous Cell Carcinoma (ESCC). Examining the chromatin accessibility of ESCC at single-cell level is imperative...
3.
Xu Y, Chen Y, Zhang J, Wang J, Yang S, Zhao H, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2411888.
PMID: 39903758
Metastasis remains a significant challenge in the treatment of hepatocellular carcinoma (HCC). The role of ribonuclease T2 (RNASET2) in HCC is still uncertain, although it has been reported to have...
4.
Zhao Y, Long F, Wu X, Lei J, Ma X, Luan X
Geriatr Nurs
. 2024 Nov;
61:311-315.
PMID: 39577378
Aims: The purpose of this study was to explore the dose-response relationship between the age at diagnosis of cardiovascular metabolic multimorbidity and cognitive impairment among middle-aged and older adults in...
5.
Wang J, Chen Y, Xu Y, Zhang J, Yang S, Zhou Y, et al.
Theranostics
. 2024 Oct;
14(17):6798-6817.
PMID: 39479454
The introduction of combination therapy utilizing tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors for advanced hepatocellular carcinoma (HCC) has significantly altered the management of affected patients. However, the absence...
6.
Ren X, Li Y, Feng T, Lei J, Cheng L
Environ Sci Pollut Res Int
. 2024 Oct;
31(51):61049-61059.
PMID: 39402362
In China, antibiotic mycelial residue is categorized as hazardous waste. To achieve the harmless and resourceful disposal of cephalosporin, three types of biochars from cephalosporin mycelia residues, namely non-activated carbon...
7.
Zhang J, Lei J, Liu X, Zhang N, Wu L, Li Y
Anal Chim Acta
. 2024 Oct;
1329:343235.
PMID: 39396298
No abstract available.
8.
Ren R, Chen Y, Zhou Y, Shen L, Chen Y, Lei J, et al.
Genes Dis
. 2024 Sep;
11(6):101281.
PMID: 39281833
Dysregulated calcium (Ca) signaling pathways are associated with tumor cell death and drug resistance. In non-excitable cells, such as hepatocellular carcinoma (HCC) cells, the primary pathway for Ca influx is...
9.
Shen L, Wang C, Ren R, Liu X, Zhou D, Chen Y, et al.
Inflamm Res
. 2024 Jul;
73(9):1493-1510.
PMID: 38981913
Objective And Design: Compelling evidence indicates that dysregulated macrophages may play a key role in driving inflammation in inflammatory bowel disease (IBD). Fibroblast growth factor (FGF)-19, which is secreted by...
10.
Chen Y, Zhou Y, Ren R, Chen Y, Lei J, Li Y
J Immunother Cancer
. 2024 Jul;
12(7).
PMID: 38977328
Background: While anti-programmed cell death protein-1 (PD-1) monotherapy has shown effectiveness in treating lung cancer, its response rate is limited to approximately 20%. Recent research suggests that abnormal lipid metabolism...